Olivier Michielin - ARCHIVE

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


290 publications

... | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1994 |
 
Pulmonary sarcoid-like granulomatosis induced by ipilimumab.
Berthod G., Lazor R., Letovanec I., Romano E., Noirez L., Mazza Stalder J., Speiser D.E., Peters S., Michielin O., 2012. Journal of Clinical Oncology, 30 (17) pp. e156-e159.
 
Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition.
Röhrig U.F., Majjigapu S.R., Grosdidier A., Bron S., Stroobant V., Pilotte L., Colau D., Vogel P., Van den Eynde B.J., Zoete V. et al., 2012. Journal of Medicinal Chemistry, 55 (11) pp. 5270-5290. Peer-reviewed.
 
Recommandations pour la prise en charge du mélanome
Bron L., Cerottini J.P., Dietrich P.Y., Gugerli O., Guggisberg D., Legal F.A., Matter M., Matzinger O., Michielin O., Voelte V., 2012., 3e édition [44], Groupe Mélanome Lémanique.
 
Sequence determinants of a microtubule tip localization signal (MtLS).
Buey R.M., Sen I., Kortt O., Mohan R., Gfeller D., Veprintsev D., Kretzschmar I., Scheuermann J., Neri D., Zoete V. et al., 2012. Journal of Biological Chemistry, 287 (34) pp. 28227-28242. Peer-reviewed.
T-Cell Receptors Binding Orientation over Peptide/MHC Class I Is Driven by Long-Range Interactions.
Ferber M., Zoete V., Michielin O., 2012. PLoS One, 7 (12) pp. e51943.
Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cells.
Baumgaertner P., Jandus C., Rivals J.P., Derré L., Lövgren T., Baitsch L., Guillaume P., Luescher I.F., Berthod G., Matter M. et al., 2012. International Journal of Cancer. Journal International Du Cancer, 130 (11) pp. 2607-2617.
 
Fast docking using the CHARMM force field with EADock DSS.
Grosdidier A., Zoete V., Michielin O., 2011. Journal of Computational Chemistry, 32 (10) pp. 2149-2159.
 
Homology-based identification of capsid determinants that protect HIV1 from human TRIM5{alpha} restriction.
Maillard P.V., Zoete V., Michielin O., Trono D., 2011. Journal of Biological Chemistry, 286 (10) pp. 8128-8140.
 
How T cell receptors interact with peptide-MHCs: A multiple steered molecular dynamics study.
Cuendet M.A., Zoete V., Michielin O., 2011. Proteins, 79 (11) pp. 3007-3024.
Identification of human IKK-2 inhibitors of natural origin (part I): modeling of the IKK-2 kinase domain, virtual screening and activity assays.
Sala E., Guasch L., Iwaszkiewicz J., Mulero M., Salvadó M.J., Pinent M., Zoete V., Grosdidier A., Garcia-Vallvé S., Michielin O. et al., 2011. Plos One, 6 (2) pp. e16903.
 
Identification of human IKK-2 inhibitors of natural origin (Part II): in Silico prediction of IKK-2 inhibitors in natural extracts with known anti-inflammatory activity.
Sala E., Guasch L., Iwaszkiewicz J., Mulero M., Salvadó M.J., Bladé C., Ceballos M., Valls C., Zoete V., Grosdidier A. et al., 2011. European Journal of Medicinal Chemistry, 46 (12) pp. 6098-6103.
 
Mélanome: une nouvette ère thérapeutique [Melanoma: a new therapeutic era].
Berthod G., Homicsko K., Bouchaab H., Matter M., Cerottini J.P., Guggisberg D., Speiser D., Leyvraz S., Michielin O., 2011. Revue Médicale Suisse, 7 (296) pp. 1126-1130.
 
Optimal CD8 T cell responsiveness is controlled within a defined TCR affinity window
Hebeisen M., Irving M., Schmid D., Zoete V., Romero P., Speiser D., Michielin O., Rufer N., 2011. p. 111 dans Annual Congress SGAI-SSAI, Advances in immunology and allergology: from research to diagnosis and therapy, Allergologie. Peer-reviewed.
 
Sentinel nodes and and non sentinel nodes evaluation in T1 melanoma patients
Matter M., Boubaker A., Michielin O., Demartines N., 2011. pp. 7-8 dans 98th Annual Congress of the Swiss Society of Surgery, British Journal of Surgery. Peer-reviewed.
 
Single cell analysis reveals similar functional competence of dominant and non-dominant CD8 T-cell clonotypes
Rufer N., Wieckowski S., Gupta B., Iancu E., Baumgaertner P., Michielin O., Romero P., Speiser D., 2011. p. 108 dans Annual Congress SGAI-SSAI, Advances in immunology and allergology: from research to diagnosis and therapy, Allergologie. Peer-reviewed.
Single cell analysis reveals similar functional competence of dominant and nondominant CD8 T-cell clonotypes.
Speiser D.E., Wieckowski S., Gupta B., Iancu E.M., Baumgaertner P., Baitsch L., Michielin O., Romero P., Rufer N., 2011. Proceedings of the National Academy of Sciences of the United States of America, 108 (37) pp. 15318-15323.
 
Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities.
Bulliard Y., Narvaiza I., Bertero A., Peddi S., Röhrig U.F., Ortiz M., Zoete V., Castro-Díaz N., Turelli P., Telenti A. et al., 2011. Journal of Virology, 85 (4) pp. 1765-1776.
SwissDock, a protein-small molecule docking web service based on EADock DSS.
Grosdidier A., Zoete V., Michielin O., 2011. Nucleic Acids Research, 39 (Suppl. 2) pp. W270-W277.
 
SwissParam: a fast force field generation tool for small organic molecules.
Zoete V., Cuendet M.A., Grosdidier A., Michielin O., 2011. Journal of Computational Chemistry, 32 (11) pp. 2359-2368.
TCRep 3D: an automated in silico approach to study the structural properties of TCR repertoires.
Leimgruber A., Ferber M., Irving M., Hussain-Kahn H., Wieckowski S., Derré L., Rufer N., Zoete V., Michielin O., 2011. PLoS One, 6 (10) pp. e26301.
 
The V-ATPase proteolipid cylinder promotes the lipid-mixing stage of SNARE-dependent fusion of yeast vacuoles.
Strasser B., Iwaszkiewicz J., Michielin O., Mayer A., 2011. EMBO Journal, 30 (20) pp. 4126-4141.
 
Unique spectrum of activity of prosimian TRIM5alpha against exogenous and endogenous retroviruses.
Rahm N., Yap M., Snoeck J., Zoete V., Muñoz M., Radespiel U., Zimmermann E., Michielin O., Stoye J.P., Ciuffi A. et al., 2011. Journal of Virology, 85 (9) pp. 4173-4183.
A combined computational and functional approach identifies new residues involved in pH-dependent gating of ASIC1a.
Liechti L.A., Bernèche S., Bargeton B., Iwaszkiewicz J., Roy S., Michielin O., Kellenberger S., 2010. Journal of Biological Chemistry, 285 (21) pp. 16315-16329.
 
A single mutation in enzyme I of the sugar phosphotransferase system confers penicillin tolerance to Streptococcus gordonii.
Bizzini A., Entenza J.M., Michielin O., Arnold I., Erni B., Moreillon P., 2010. Antimicrobial Agents and Chemotherapy, 54 (1) pp. 259-266.
BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination.
Derré L., Rivals J.P., Jandus C., Pastor S., Rimoldi D., Romero P., Michielin O., Olive D., Speiser D.E., 2010. Journal of Clinical Investigation, 120 (1) pp. 157-167.
 
Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function.
Schmid D.A., Irving M.B., Posevitz V., Hebeisen M., Posevitz-Fejfar A., Sarria J.C., Gomez-Eerland R., Thome M., Schumacher T.N., Romero P. et al., 2010. Journal of Immunology, 184 (9) pp. 4936-4946. Peer-reviewed.
 
Fourier transform convolution integrals applied to generalized Born molecular volume.
Schüpbach T., Zoete V., Tsakam-Sotché B., Michielin O., 2010. Journal of Computational Chemistry, 31 (3) pp. 649-659.
Frequent MAGE mutations in human melanoma.
Caballero O.L., Zhao Q., Rimoldi D., Stevenson B.J., Svobodová S., Devalle S., Röhrig U.F., Pagotto A., Michielin O., Speiser D. et al., 2010. PLoS One, 5 (9) pp. e12773.
 
MM-GBSA binding free energy decomposition and T cell receptor engineering.
Zoete V., Irving M.B., Michielin O., 2010. Journal of Molecular Recognition, 23 (2) pp. 142-152.
 
Rational design of indoleamine 2,3-dioxygenase inhibitors.
Röhrig U.F., Awad L., Grosdidier A., Larrieu P., Stroobant V., Colau D., Cerundolo V., Simpson A.J., Vogel P., Van den Eynde B.J. et al., 2010. Journal of Medicinal Chemistry, 53 (3) pp. 1172-1189.
 
Use of the FACTS solvation model for protein-ligand docking calculations. Application to EADock.
Zoete V., Grosdidier A., Cuendet M., Michielin O., 2010. Journal of Molecular Recognition, 23 (5) pp. 457-461.
 
Blind docking of 260 protein-ligand complexes with EADock 2.0.
Grosdidier A., Zoete V., Michielin O., 2009. Journal of Computational Chemistry, 30 (13) pp. 2021-2030.
 
Docking to heme proteins.
Röhrig U.F., Grosdidier A., Zoete V., Michielin O., 2009. Journal of Computational Chemistry, 30 (14) pp. 2305-2315.
Docking, virtual high throughput screening and in silico fragment-based drug design.
Zoete V., Grosdidier A., Michielin O., 2009. Journal of Cellular and Molecular Medicine, 13 (2) pp. 238-248. Peer-reviewed.
 
Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor.
Prior J.O., Montemurro M., Orcurto M.V., Michielin O., Luthi F., Benhattar J., Guillou L., Elsig V., Stupp R., Delaloye A.B. et al., 2009. Journal of Clinical Oncology, 27 (3) pp. 439-445. Peer-reviewed.
 
Functional analysis and structural modeling of human APOBEC3G reveal the role of evolutionarily conserved elements in the inhibition of human immunodeficiency virus type 1 infection and Alu transposition.
Bulliard Y., Turelli P., Röhrig U.F., Zoete V., Mangeat B., Michielin O., Trono D., 2009. Journal of Virology, 83 (23) pp. 12611-12621.
Inhibition of the shade avoidance response by formation of non-DNA binding bHLH heterodimers.
Hornitschek P., Lorrain S., Zoete V., Michielin O., Fankhauser C., 2009. EMBO journal, 28 (24) pp. 3893-3902.
 
Molecular Modeling of Proteins: From Simulations to Drug Design Applications
Zoete V., Cuendet M, Röhrig U.F., Grosdidier A., Michielin O., 2009. pp. 247-281 dans Appel R.D., Feytmans E. (eds.) Bioinformatics: s swiss perspective, World Scientific.
 
Temozolomide combined with bevacizumab in metastatic melanoma. A multicenter phase II trial (SAKK 50/07)
Von Moos R., Seifert B., Ochsenbein A., Cathomas R., Schlaeppi M., Gillessen S., Schuller J.C., Michielin O., Goldinger S., Dummer R., 2009. pp. 13-14 dans 15th ECCO/34th ESMO Multidisciplinary Congress, Ejc Supplements. Peer-reviewed.
 
Molecular Dynamics-based Free Energy Simulations
Cuendet M. A., Zoete V., Michielin O., 2008/05., WORLD SCIENTIFIC.
Characterization of Melan-A reactive memory CD8+ T cells in a healthy donor.
Voelter V., Rufer N., Reynard S., Greub G., Brookes R., Guillaume P., Grosjean F., Fagerberg T., Michielin O., Rowland-Jones S. et al., 2008. International Immunology, 20 (8) pp. 1087-1096. Peer-reviewed.
Distinct sets of alphabeta TCRs confer similar recognition of tumor antigen NY-ESO-1157-165 by interacting with its central Met/Trp residues.
Derré L., Bruyninx M., Baumgaertner P., Ferber M., Schmid D., Leimgruber A., Zoete V., Romero P., Michielin O., Speiser D.E. et al., 2008. Proceedings of the National Academy of Sciences of the United States of America, 105 (39) pp. 15010-15015. Peer-reviewed.
 
In vitro biotransformation of imatinib by the tumor expressed CYP1A1 and CYP1B1.
Rochat B., Zoete V., Grosdidier A., von Grünigen S., Marull M., Michielin O., 2008. Biopharmaceutics and drug disposition, 29 (2) pp. 103-118. Peer-reviewed.
Local alignment refinement using structural assessment.
Chodanowski P., Grosdidier A., Feytmans E., Michielin O., 2008. PLoS ONE, 3 (7) pp. e2645. Peer-reviewed.
 
Nouveautés dans l'immunothérapie du cancer [New developments in cancer immunotherapy]
Michielin O., Rufer N., Romero P., Laurent J., Cerottini J.P., Gugisberg D., Leyvraz S., Speiser D., 2008. Revue Médicale Suisse, 4 (158) pp. 1248-1251.
 
Protein-protein interaction investigated by steered molecular dynamics: the TCR-pMHC complex.
Cuendet M.A., Michielin O., 2008. Biophysical journal, 95 (8) pp. 3575-3590.
 
The fourth extracellular loop of the alpha subunit of Na,K-ATPase. Functional evidence for close proximity with the second extracellular loop.
Capendeguy O., Iwaszkiewicz J., Michielin O., Horisberger J.D., 2008. Journal of Biological Chemistry, 283 (41) pp. 27850-27858. Peer-reviewed.
A novel population of human melanoma-specific CD8 T cells recognizes Melan-AMART-1 immunodominant nonapeptide but not the corresponding decapeptide.
Derré L., Ferber M., Touvrey C., Devevre E., Zoete V., Leimgruber A., Romero P., Michielin O., Lévy F., Speiser D.E., 2007. Journal of Immunology, 179 (11) pp. 7635-7645.
 
Application de la modélisation moléculaire à de nouvelles approches thérapeutiques du cancer [Application of molecular modeling to new therapeutic cancer approaches].
Michielin O., 2007. Bulletin du Cancer, 94 (9) pp. 763-768.
 
Combined simulation and mutagenesis analyses reveal the involvement of key residues for peroxisome proliferator-activated receptor alpha helix 12 dynamic behavior.
Michalik L., Zoete V., Krey G., Grosdidier A., Gelman L., Chodanowski P., Feige J.N., Desvergne B., Wahli W., Michielin O., 2007. Journal of Biological Chemistry, 282 (13) pp. 9666-9677. Peer-reviewed.
 
Comparison between computational alanine scanning and per-residue binding free energy decomposition for protein-protein association using MM-GBSA: application to the TCR-p-MHC complex.
Zoete V., Michielin O., 2007. Proteins, 67 (4) pp. 1026-1047.
 
EADock: docking of small molecules into protein active sites with a multiobjective evolutionary optimization.
Grosdidier A., Zoete V., Michielin O., 2007. Proteins, 67 (4) pp. 1010-1025.
Immunogenicity of the carcinoembryonic antigen derived peptide 694 in HLA-A2 healthy donors and colorectal carcinoma patients.
Alves P.M., Viatte S., Fagerberg T., Michielin O., Bricard G., Bouzourene H., Vuilleumier H., Kruger T., Givel J.C., Lévy F. et al., 2007. Cancer immunology, immunotherapy, 56 (11) pp. 1795-1805. Peer-reviewed.
Model structure of human APOBEC3G.
Zhang K.L., Mangeat B., Ortiz M., Zoete V., Trono D., Telenti A., Michielin O., 2007. PLoS ONE, 2 (4) pp. e378. Peer-reviewed.
 
Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators.
Zoete V., Grosdidier A., Michielin O., 2007. Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids, 1771 (8) pp. 915-925. Peer-reviewed.
 
Silencing of both beta-TrCP1 and HOS (beta-TrCP2) is required to suppress human immunodeficiency virus type 1 Vpu-mediated CD4 down-modulation.
Butticaz C., Michielin O., Wyniger J., Telenti A., Rothenberger S., 2007. Journal of virology, 81 (3) pp. 1502150-5. Peer-reviewed.
 
The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis.
Feige J.N., Gelman L., Rossi D., Zoete V., Métivier R., Tudor C., Anghel S.I., Grosdidier A., Lathion C., Engelborghs Y. et al., 2007. Journal of Biological Chemistry, 282 (26) pp. 19152-19166. Peer-reviewed.
 
Un guide pratique au traitement des gliomes [A practical guide for the management of gliomas]
Stupp R., Pica A., Mirimanoff R.O., Michielin O., 2007. Bulletin du cancer, 94 (9) pp. 817-22.
 
A natural structural variant of the mouse TCR beta-chain displays intrinsic receptor function and antigen specificity.
Aublin A., Ciofani M., Willkomm N., Hamrouni A., Szymczak-Workman A.L., Takahashi T., Sandjeu Y., Guillaume P., Vignali D.A., Michielin O. et al., 2006. Journal of immunology, 177 (12) pp. 8587-8594. Peer-reviewed.
Access of extracellular cations to their binding sites in Na,K-ATPase: role of the second extracellular loop of the alpha subunit.
Capendeguy O., Chodanowski P., Michielin O., Horisberger J.D., 2006. The Journal of general physiology, 127 (3) pp. 341-s52. Peer-reviewed.
 
Impact of orthologous melan-A peptide immunizations on the anti-self melan-A/HLA-A2 T cell cross-reactivity.
Colombetti S., Fagerberg T., Baumgärtner P., Chapatte L., Speiser D.E., Rufer N., Michielin O., Lévy F., 2006. Journal of Immunology, 176 (11) pp. 6560-6567. Peer-reviewed.
 
Structural assessment of single amino acid mutations: application to TP53 function.
Yip Y.L., Zoete V., Scheib H., Michielin O., 2006. Human mutation, 27 (9) pp. 926-937.
 
Structural prediction of peptides bound to MHC class I.
Fagerberg T., Cerottini J.C., Michielin O., 2006. Journal of molecular biology, 356 (2) pp. 521-546. Peer-reviewed.
 
CD8+ cytotoxic T lymphocyte activation by soluble major histocompatibility complex-peptide dimers.
Cebecauer M., Guillaume P., Mark S., Michielin O., Boucheron N., Bezard M., Meyer B.H., Segura J.M., Vogel H., Luescher I.F., 2005. The Journal of biological chemistry, 280 (25) pp. 23820-23828. Peer-reviewed.
 
Chimioprévention actuelle et visions futures [Present chemoprevention and future vision].
Filges I., Zaman K., Michielin O., Vulliémoz D., Perey L., Stupp R., 2005. Revue Médicale Suisse, 1 (20) pp. 1343-6, 1349.
 
Functional dynamics of PDZ binding domains: a normal-mode analysis.
De Los Rios P., Cecconi F., Pretre A., Dietler G., Michielin O., Piazza F., Juanico B., 2005. Biophysical journal, 89 (1) pp. 14-21. Peer-reviewed.
 
Structure-function characterization and optimization of a plant-derived antibacterial peptide.
Suarez M., Haenni M., Canarelli S., Fisch F., Chodanowski P., Servis C., Michielin O., Freitag R., Moreillon P., Mermod N., 2005. Antimicrobial Agents and Chemotherapy, 49 (9) pp. 3847-3857.
 
Tinkering with nature: the tale of optimizing peptide based cancer vaccines.
Michielin O., Blanchet J.S., Fagerberg T., Valmori D., Rubio-Godoy V., Speiser D., Ayyoub M., Alves P., Luescher I., Gairin J.E. et al., 2005. Cancer treatment and research, 123 pp. 267-291.
 
A template-assembled synthetic protein surface mimetic of the von Willebrand factor A1 domain inhibits botrocetin-induced platelet aggregation.
Hauert J., Fernandez-Carneado J., Michielin O., Mathieu S., Grell D., Schapira M., Spertini O., Mutter M., Tuchscherer G., Kovacsovics T., 2004. Chembiochem, 5 (6) pp. 856-864. Peer-reviewed.
 
Irinotecan-induced interstitial pneumonia.
Michielin O., Udry E., Périard D., Matzinger O., Lobrinus J.A., Stupp R., 2004. Lancet Oncology, 5 (5) pp. 322-324. Peer-reviewed.
 
Structural and functional interaction sites between Na,K-ATPase and FXYD proteins.
Li C., Grosdidier A., Crambert G., Horisberger J.D., Michielin O., Geering K., 2004. The Journal of biological chemistry, 279 (37) pp. 38895-902. Peer-reviewed.
 
The fourth transmembrane segment of the Na,K-ATPase alpha subunit: a systematic mutagenesis study.
Horisberger J.D., Kharoubi-Hess S., Guennoun S., Michielin O., 2004. The Journal of biological chemistry, 279 (28) pp. 29542-50. Peer-reviewed.
 
Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1.
Schwitzgebel V.M., Mamin A., Brun T., Ritz-Laser B., Zaiko M., Maret A., Jornayvaz F.R., Theintz G.E., Michielin O., Melloul D. et al., 2003. The Journal of clinical endocrinology and metabolism, 88 (9) pp. 4398-406. Peer-reviewed.
 
CD3 delta establishes a functional link between the T cell receptor and CD8.
Doucey M.A., Goffin L., Naeher D., Michielin O., Baumgärtner P., Guillaume P., Palmer E., Luescher I.F., 2003. Journal of Biological Chemistry, 278 (5) pp. 3257-3264. Peer-reviewed.
 
Molecular basis of leukocyte rolling on PSGL-1. Predominant role of core-2 O-glycans and of tyrosine sulfate residue 51.
Bernimoulin M.P., Zeng X.L., Abbal C., Giraud S., Martinez M., Michielin O., Schapira M., Spertini O., 2003. The Journal of biological chemistry, 278 (1) pp. 37-47. Peer-reviewed.
 
Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen.
Dietrich P.Y., Le Gal F.A., Dutoit V., Pittet M.J., Trautman L., Zippelius A., Cognet I., Widmer V., Walker P.R., Michielin O. et al., 2003. Journal of Immunology, 170 (10) pp. 5103-5109.
 
Protein-ligand binding free energy estimation using molecular mechanics and continuum electrostatics. Application to HIV-1 protease inhibitors.
Zoete V., Michielin O., Karplus M., 2003. Journal of computer-aided molecular design, 17 (12) pp. 861-880. Peer-reviewed.
 
Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma.
Romero P., Valmori D., Pittet M.J., Zippelius A., Rimoldi D., Lévy F., Dutoit V., Ayyoub M., Rubio-Godoy V., Michielin O. et al., 2002. Immunological reviews, 188 pp. 81-96. Peer-reviewed.
 
Binding free energy differences in a TCR-peptide-MHC complex induced by a peptide mutation: a simulation analysis.
Michielin O., Karplus M., 2002. Journal of molecular biology, 324 (3) pp. 547-569. Peer-reviewed.
 
Conformational analysis of a stereochemically complete set of cis-enediol peptide analogues.
Michielin O., Zoete V., Gierasch T.M., Eckstein J., Napper A., Verdine G., Karplus M., 2002. Journal of the American Chemical Society, 124 (37) pp. 11131-11141. Peer-reviewed.
 
Relation between sequence and structure of HIV-1 protease inhibitor complexes: a model system for the analysis of protein flexibility.
Zoete V., Michielin O., Karplus M., 2002. Journal of molecular biology, 315 (1) pp. 21-52. Peer-reviewed.
 
Crystal structures of two closely related but antigenically distinct HLA-A2/melanocyte-melanoma tumor-antigen peptide complexes.
Sliz P., Michielin O., Cerottini J.C., Luescher I., Romero P., Karplus M., Wiley D.C., 2001. Journal of immunology, 167 (6) pp. 3276-3284. Peer-reviewed.
 
Modeling of the TCR-MHC-peptide complex.
Michielin O., Luescher I., Karplus M., 2000. Journal of molecular biology, 300 (5) pp. 1205-1235. Peer-reviewed.
 
Myristoylation-Induced Compaction of a Membrane-Binding Protein
Michielin Olivier, Vergères Guy, Ramsden Jeremy J., 1999/07. Journal of the American Chemical Society, 121 (28) pp. 6523-6526.
 
Dramatic influence of V beta gene polymorphism on an antigen-specific CD8+ T cell response in vivo.
Bour H., Michielin O., Bousso P., Cerottini J.C., MacDonald H.R., 1999. Journal of immunology, 162 (8) pp. 4647-4656. Peer-reviewed.
 
T cell recognition of hapten. Anatomy of T cell receptor binding of a H-2kd-associated photoreactive peptide derivative.
Kessler B., Michielin O., Blanchard C.L., Apostolou I., Delarbre C., Gachelin G., Grégoire C., Malissen B., Cerottini J.C., Wurm F. et al., 1999. The Journal of biological chemistry, 274 (6) pp. 3622-3631. Peer-reviewed.
 
Unmyristoylated MARCKS-related protein (MRP) binds to supported planar phosphatidylcholine membranes
Michielin Olivier, Ramsden Jeremy J., Vergères Guy, 1998/10. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1375 (1-2) pp. 110-116. Peer-reviewed.
 
Map Dynamics Study of the Lorenz Equations
Michielin Olivier, Phillipson Paul E., 1997/02. International Journal of Bifurcation and Chaos, 07 (02) pp. 373-382.
 
Construction of Poincaré maps for multiply periodic and chaotic flows
Michielin Olivier, Phillipson Paul E, 1994/05. Physics Letters A, 188 (4-6) pp. 309-316.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University